the present invention relates to stable liquid pharmaceutical compositions of curcumin or its pharmaceutically acceptable salts or its derivatives with higher curcumin concentration and improved bioavailability without the use of buffer and / or molecular aggregation inhibitor . in accordance with present invention the curcumin is in the solubilized form to make a stable liquid pharmaceutical composition .